approved EB-2 (NIW)

Ph.D. Candidate & Graduate Researcher

Biotherapeutics · China · 2025-07-30

Processing Time
643 days
Decision Date
2025-07-30
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to investigate the molecular processes of protein misfolding to advance therapeutic strategies for neurodegenerative disorders, cancer, and diabetes. His work focuses on identifying how aberrant protein structures can be corrected or leveraged to design cost-effective treatment platforms grounded in structural biochemistry.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses urgent scientific and public health needs related to debilitating illnesses and is supported by federal interest from agencies like the NIH and DOD.

2 Well-positioned to Advance the Endeavor Met

The petitioner's advanced education, publication record in high-impact journals, and citation history demonstrate his expertise and influence in biotherapeutics.

3 Balance of Interests Met

The strength of the research record and the potential for cost-effective treatment platforms made it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of four peer-reviewed journal articles and 91 citations, including a paper in Nature Chemistry ranked in the top 0.01% of its field. He also completed five peer reviews and demonstrated alignment with federal research priorities. The case satisfied all three Dhanasar prongs by showing the national importance of biotherapeutic innovation and the petitioner's strong positioning in the field.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 476 days 2025-03-14
The petitioner proposes to continue research in structural biology and drug discovery, specifically focusing on the three-dimensional structures of human membrane proteins linked to rare diseases. This work involves using cryo-electron microscopy and mammalian host cells to identify critical features for developing innovative antibodies and small-molecule inhibitors. The goal is to advance targeted treatment strategies for infectious diseases, cancer, and rare conditions.

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Washington 369 days 2025-02-05
The petitioner proposes to advance computational algorithms and experimental screening techniques to streamline the creation of modular, low-cost, and efficient protein therapeutics. This work focuses on improving the stability and production of drugs like antibodies and insulins to eliminate cold-chain transportation barriers and reduce healthcare costs.

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 95 days 2022-04-11
The petitioner proposes to continue research evaluating how changes in RNA impact protein synthesis and influence the progression of health burdens including cancer, aging, and infectious diseases. He utilizes expertise in RNA folding, ribosome assembly, and protein synthesis mechanisms to identify novel therapeutic targets for these disorders.

Scientist

Biotechnology · Albania

WeGreened EB-2 (NIW) approved
California 64 days 2025-02-10
The petitioner proposes to continue her research in molecular biology, specifically focusing on identifying drug targets and their mechanisms of action in complex biological samples. Her work utilizes proteogenomic approaches to elucidate the relationship between genetic mutations and protein functions in breast cancer. This research is intended to enhance the understanding of disease mechanisms and inform the development of targeted therapies for cancer, metabolic disorders, and neurodegenerative conditions.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 643 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist